Ivanov I., Bansal R., Hao X., Zhu H., Kellendonk C., Miller L., Sanchez-Pena J., Miller A. M., Chakravarty M., Klahr K., Durkin K., Greenhill L. L., Peterson B. S. (2010). Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder, Am J Psychiatry, 167(4), 397-408. En savoir plus.

Jespersen S. N., Bjarkam C. R., Nyengaard J. R., Chakravarty M., Hansen B., Vosegaard T., Ostergaard L., Yablonskiy D., Nielsen N. C., Vestergaard-Poulsen P. (2010). Neurite density from magnetic resonance diffusion measurements at ultrahigh field: comparison with light microscopy and electron microscopy, Neuroimage, 49(1), 205-16. En savoir plus.

Khachaturian Z. S., Barnes D., Einstein R., Johnson S., Lee V., Roses A., Sager M. A., Shankle W. R., Snyder P. J., Petersen R. C., Schellenberg G., Trojanowski J., Aisen P., Albert M. S., Breitner J., Buckholtz N., Carrillo M., Ferris S., Greenberg B. D., Grundman M., Khachaturian A. S., Kuller L. H., Lopez O. L., Maruff P., Mohs R. C., Morrison-Bogorad M., Phelps C., Reiman E., Sabbagh M., Sano M., Schneider L. S., Siemers E., Tariot P., Touchon J., Vellas B., Bain L. J. (2010). Developing a national strategy to prevent dementia: Leon Thal Symposium 2009, Alzheimers Dement, 6(2), 89-97. En savoir plus.

Khalili-Mahani N., Dedovic K., Engert V., Pruessner J. (2010). Hippocampal activation during a cognitive task is associated with subsequent neuroendocrine and cognitive responses to psychological stress, Hippocampus, 20(2), 323-34.

La Fougere C., Boning G., Bartmann H., Wangler B., Nowak S., Just T., Wagner E., Winter P., Rominger A., Forster S., Gildehaus F.J., Rosa-Neto P., Minuzzi L., Bartenstein P., Potschka H., Cumming P. (2010). Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar, Neuroimage, 49(2), 1406-1415.

Leduc V., Jasmin-Bélanger S., Poirier J. (2010). APOE and cholesterol homeostasis in Alzheimer's disease, Trends Mol Med.

Leh S. E., Ptito A., Schonwiesner M., Chakravarty M., Mullen K. T. (2010). Blindsight mediated by an S-cone-independent collicular pathway: an fMRI study in hemispherectomized subjects, J Cogn Neurosci, 22(4), 670-82. En savoir plus.

Li G., Shofer J. B., Rhew I. C., Kukull W. A., Peskind E. R., McCormick W., Bowen J. D., Schellenberg G. D., Crane P. K., Breitner J., Larson E. B. (2010). Age-varying association between statin use and incident Alzheimer's disease, J Am Geriatr Soc, 58(7), 1311-7. En savoir plus.

Lord C., Engert V., Lupien S.J., Pruessner J. (2010). Effect of sex and estrogen therapy on the aging brain: a voxel-based morphometry study, Menopause, 17(4), 846-851.

Ma W., Chabot J. G., Vercauteren F., Quirion R. (2010). Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats, Neurobiol Aging, 31(7), 1227-1237.

Ma W., Dumont Y., Vercauteren F., Quirion R. (2010). Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line, Immunology, 15 (1 ), 76-83.

Mahaut S., Dumont Y., Fournier A., Quirion R., Moyse E. (2010). Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat, Neuropeptides, 44(2), 77-86.

Marca R.L., Waldvogel P., Thorn H., Tripod M., Wirtz P.H., Pruessner J., Ehlert U. (2010). Association between Cold Face Test-induced vagal inhibition and cortisol response to acute stress, Psychophysiology.

Marceau F., Quirion R. (2010). Guest editorial for the special issue peptide receptors: focus on neuropeptides and kinins, Neuropeptides, 44(2), 65-67.

Massoud F., Gauthier S. (2010). Update on the pharmacological treatment of Alzheimer's disease, Curr Neuropharmacol, 8(1), 69-80. En savoir plus.

Matousek R. H., Dobkin P. L., Pruessner J. (2010). Cortisol as a marker for improvement in mindfulness-based stress reduction, Complement Ther Clin Pract, 16(1), 13-9. En savoir plus.

McGirr A., Diaconu G., Berlim M.T., Pruessner J., Sable R., Cabot S., Turecki G. (2010). Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide, J Psychiatry Neurosci, 35(6), 399-408.

Miller A. M., Bansal R., Hao X., Sanchez-Pena J. P., Sobel L. J., Liu J., Xu D., Zhu H., Chakravarty M., Durkin K., Ivanov I., Plessen K. J., Kellendonk C. B., Peterson B. S. (2010). Enlargement of thalamic nuclei in Tourette syndrome, Arch Gen Psychiatry, 67(9), 955-64. En savoir plus.

Montine T. J., Sonnen J. A., Milne G., Baker L. D., Breitner J. (2010). Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT, PLoS One, 5(2), e9340. En savoir plus.

Moorhouse P., Song X., Rockwood K., Black S., Kertesz A., Gauthier S., Feldman H. (2010). Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study, J Neurol Sci, 288(1-2), 142-6.